AUD 1.07
(0.47%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 13.38 Million AUD | 1.22% |
2022 | 13.21 Million AUD | 37.17% |
2021 | 9.63 Million AUD | -5.17% |
2020 | 10.16 Million AUD | -5.53% |
2019 | 10.75 Million AUD | 31.44% |
2018 | 8.18 Million AUD | 6.27% |
2017 | 7.7 Million AUD | 50.32% |
2016 | 5.12 Million AUD | 31.89% |
2015 | 3.88 Million AUD | -48.46% |
2014 | 7.53 Million AUD | -15.64% |
2013 | 8.93 Million AUD | 13.9% |
2012 | 7.84 Million AUD | 5.17% |
2011 | 7.45 Million AUD | 26.26% |
2010 | 5.9 Million AUD | -22.81% |
2009 | 7.65 Million AUD | 22.32% |
2008 | 6.25 Million AUD | -3.68% |
2007 | 6.49 Million AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 6.77 Million AUD | 0.0% |
2023 Q4 | 5.86 Million AUD | 0.0% |
2023 FY | 13.38 Million AUD | 1.22% |
2023 Q2 | 7.27 Million AUD | 0.0% |
2022 Q2 | 5.31 Million AUD | 0.0% |
2022 Q4 | 7.72 Million AUD | 0.0% |
2022 FY | 13.21 Million AUD | 37.17% |
2021 Q2 | 5.16 Million AUD | 0.0% |
2021 Q4 | 4.49 Million AUD | 0.0% |
2021 FY | 9.63 Million AUD | -5.17% |
2020 FY | 10.16 Million AUD | -5.53% |
2020 Q4 | 4.49 Million AUD | 0.0% |
2020 Q2 | 5.53 Million AUD | 0.0% |
2019 FY | 10.75 Million AUD | 31.44% |
2019 Q4 | 5.53 Million AUD | 0.0% |
2019 Q2 | 5.04 Million AUD | 0.0% |
2018 Q4 | 6.26 Million AUD | 0.0% |
2018 FY | 8.18 Million AUD | 6.27% |
2018 Q2 | 6.25 Million AUD | 0.0% |
2017 Q4 | 6.18 Million AUD | 0.0% |
2017 FY | 7.7 Million AUD | 50.32% |
2017 Q2 | 6.1 Million AUD | 0.0% |
2016 Q2 | 4.53 Million AUD | 0.0% |
2016 Q4 | 4.93 Million AUD | 0.0% |
2016 FY | 5.12 Million AUD | 31.89% |
2015 Q4 | 2.16 Million AUD | 0.0% |
2015 FY | 3.88 Million AUD | -48.46% |
2015 Q2 | 3.67 Million AUD | 0.0% |
2014 Q2 | 4.03 Million AUD | 0.0% |
2014 FY | 7.53 Million AUD | -15.64% |
2014 Q4 | 1.02 Million AUD | 0.0% |
2013 Q4 | 13.7 Million AUD | 0.0% |
2013 FY | 8.93 Million AUD | 13.9% |
2013 Q2 | 4.67 Million AUD | 637.73% |
2013 Q1 | 633.86 Thousand AUD | 0.0% |
2012 Q1 | 450.34 Thousand AUD | 0.0% |
2012 Q2 | 450.34 Thousand AUD | 0.0% |
2012 Q3 | 450.34 Thousand AUD | 0.0% |
2012 FY | 7.84 Million AUD | 5.17% |
2012 Q4 | 633.86 Thousand AUD | 40.75% |
2011 Q3 | 635.6 Thousand AUD | 0.0% |
2011 FY | 7.45 Million AUD | 26.26% |
2011 Q4 | 450.34 Thousand AUD | -29.15% |
2011 Q1 | 635.6 Thousand AUD | 0.0% |
2011 Q2 | 635.6 Thousand AUD | 0.0% |
2010 Q1 | 220.11 Thousand AUD | 0.0% |
2010 FY | 5.9 Million AUD | -22.81% |
2010 Q4 | 635.6 Thousand AUD | 188.76% |
2010 Q3 | 220.11 Thousand AUD | 0.0% |
2010 Q2 | 220.11 Thousand AUD | 0.0% |
2009 Q3 | 418.47 Thousand AUD | 0.0% |
2009 Q4 | 220.11 Thousand AUD | -47.4% |
2009 FY | 7.65 Million AUD | 22.32% |
2009 Q1 | 418.47 Thousand AUD | 0.0% |
2009 Q2 | 418.47 Thousand AUD | 0.0% |
2008 Q3 | 31.25 Thousand AUD | 0.0% |
2008 Q2 | 31.25 Thousand AUD | 0.0% |
2008 Q1 | 31.25 Thousand AUD | 0.0% |
2008 FY | 6.25 Million AUD | -3.68% |
2008 Q4 | 418.47 Thousand AUD | 1238.96% |
2007 Q4 | 31.25 Thousand AUD | -91.53% |
2007 Q1 | 368.88 Thousand AUD | 0.0% |
2007 Q3 | 368.88 Thousand AUD | 0.0% |
2007 Q2 | 368.88 Thousand AUD | 0.0% |
2007 FY | 6.49 Million AUD | 0.0% |
2006 Q4 | 368.88 Thousand AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 57.499% |
Adherium Limited | 267.7 Thousand AUD | -4898.388% |
Aroa Biosurgery Limited | 66.09 Million AUD | 79.757% |
Atomo Diagnostics Limited | 1.6 Million AUD | -733.176% |
Anteris Technologies Ltd | 69.14 Million AUD | 80.65% |
Control Bionics Limited | 9.82 Million AUD | -36.179% |
CardieX Limited | 16.64 Million AUD | 19.63% |
Compumedics Limited | 26.88 Million AUD | 50.22% |
Cochlear Limited | 1.17 Billion AUD | 98.861% |
CleanSpace Holdings Limited | 11.35 Million AUD | -17.796% |
EMVision Medical Devices Ltd | 12.83 Million AUD | -4.264% |
Nova Eye Medical Limited | 23.99 Million AUD | 44.223% |
HeraMED Limited | 6.78 Million AUD | -97.271% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 1299.172% |
ImpediMed Limited | 28.04 Million AUD | 52.281% |
InhaleRx Limited | 2.59 Million AUD | -416.528% |
LBT Innovations Limited | 1.1 Million AUD | -1108.747% |
Micro-X Limited | 18.76 Million AUD | 28.689% |
Neurotech International Limited | 8.75 Million AUD | -52.849% |
OncoSil Medical Limited | 12.03 Million AUD | -11.138% |
PolyNovo Limited | 34.92 Million AUD | 61.684% |
Respiri Limited | 8.03 Million AUD | -66.535% |
SomnoMed Limited | 58.97 Million AUD | 77.31% |
Universal Biosensors, Inc. | 20 Million AUD | 33.097% |
Uscom Limited | 5.52 Million AUD | -142.404% |
Visioneering Technologies, Inc. | 9.63 Million AUD | -38.897% |